CARDIOVASCULAR RISK
Clinical trials for CARDIOVASCULAR RISK explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR RISK trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in calming inflammation for kidney patients
Disease control CompletedThis study tested a drug called ziltivekimab in 36 adults with advanced chronic kidney disease and high inflammation. The goal was to see if it could safely reduce inflammation and lower heart disease risks. Participants received either a low dose, a high dose, or a placebo injec…
Matched conditions: CARDIOVASCULAR RISK
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Diabetes drug may protect hearts by reducing scarring
Disease control CompletedThis study looked at whether canagliflozin, a diabetes medicine, can reduce scarring in the heart muscle of people with type 2 diabetes who are at high risk for heart problems. 45 participants took the drug, and researchers used MRI scans to measure changes in heart scarring. The…
Matched conditions: CARDIOVASCULAR RISK
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
App-based lifestyle program shows promise for managing chronic disease
Disease control CompletedThis study tested whether a 9-month program using a smartphone app could help 520 adults with chronic conditions improve their diet, physical activity, and mental health. Participants were split into two groups: one used the app to get personalized guidance, the other received us…
Matched conditions: CARDIOVASCULAR RISK
Phase: NA • Sponsor: University of Barcelona • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Phone coaching + app may cut heart risk in thousands
Prevention CompletedThis study tested a digital health program that combines online tools with regular phone coaching from trained professionals. Over 2,600 adults voluntarily joined to improve their lifestyle habits and lower their risk of heart disease. Researchers tracked changes in cardiovascula…
Matched conditions: CARDIOVASCULAR RISK
Phase: NA • Sponsor: Vivoptim Solutions • Aim: Prevention
Last updated May 08, 2026 12:03 UTC